Whereas, activation of LKB1–AMPK signaling might contribute to the suppression of cancer risk and, thus, pharmacological modulators, such as TQ, which was shown to activate LKB1–AMPK signaling [106], could have therapeutic promise in cancer prevention. This evidence concerns the gene STK11 and cancer.